Sermonix Pharmaceuticals Closes US$26 Million Series A Financing Round Led by WILD Family Office
COLUMBUS, Ohio, July 31, 2019 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female-specific oncology products, today announced the completion of a US$26 million Series A …